Wikidata

(Q61939132)

English

A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo

clinical trial

In more languages

Statements

short name
GALA (English)
0 references
title
A Multinational, Multicenter, Randomized, Parallel-group Study Performed in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo in a Double-blind Design (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Bulgaria
0 references
Croatia
0 references
Estonia
0 references
Georgia
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Lithuania
0 references
Poland
0 references
Romania
0 references
South Africa
0 references
Ukraine
0 references
United Kingdom
0 references
start time
22 June 2010
0 references
end time
8 May 2012
0 references
number of participants
1,404
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61939132&oldid=2112950135"